These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8593738)

  • 1. New drugs in the treatment of heart failure.
    Brown L
    Clin Exp Pharmacol Physiol; 1995 Nov; 22(11):829-32. PubMed ID: 8593738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasodilators and inotropic agents in the treatment of congestive heart failure.
    Francis GS
    Semin Nephrol; 1994 Sep; 14(5):464-78. PubMed ID: 7997651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vasoactive and inotropic drugs in acute heart failure].
    Ruiz-Laiglesia FJ; Camafort-Babkowski M
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():49-54. PubMed ID: 24930084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy for heart failure].
    Just H
    Ther Umsch; 2000 May; 57(5):313-20. PubMed ID: 10859991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department.
    Kirk JD; Parissis JT; Filippatos G
    Heart Fail Clin; 2009 Jan; 5(1):43-54, vi. PubMed ID: 19026385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug treatment of left ventricular insufficiency. Current aspects].
    Jaeger P; Cohen Solal A; Dahan M; Juliard JM; Charlier P; Gourgon R
    Rev Mal Respir; 1987; 4(6):287-94. PubMed ID: 3327120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New inotropic vasodilators: what is their role in the long-term treatment of heart failure?].
    Padrini R
    G Ital Cardiol; 1987 Mar; 17(3):259-63. PubMed ID: 3301506
    [No Abstract]   [Full Text] [Related]  

  • 8. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
    Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vasodilator and inotropic drugs on clinical symptoms and long-term survival in chronic congestive heart failure.
    Packer M
    Eur Heart J; 1988 Jun; 9 Suppl H():105-8. PubMed ID: 2901957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congestive heart failure. Drug therapy: central or peripheral approach?
    Remme WJ
    Cardiologia; 1993 Dec; 38(12 Suppl 1):51-9. PubMed ID: 7912652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
    Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of resistant cardiac failure; vasodilators and new inotropic drugs].
    Herziano H; Gil I; Almog C
    Harefuah; 1980 Jun; 98(11-12):517-8. PubMed ID: 7203196
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical management of chronic heart failure: inotropic, vasodilator, or inodilator drugs?
    Lang R
    Am Heart J; 1990 Dec; 120(6 Pt 2):1558-64. PubMed ID: 1978981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology and current therapy of congestive heart failure.
    Parmley WW
    J Am Coll Cardiol; 1989 Mar; 13(4):771-85. PubMed ID: 2647811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [First-line treatment of cardiac insufficiency: digitalis glycosides, diuretics, vasodilator agents or new cardiotonic agents?].
    Komajda M; Lechat P; Grosgogeat Y
    Presse Med; 1988 Apr; 17(15):747-50. PubMed ID: 2968553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vasodilators in managing congestive heart failure.
    Franciosa JA
    Postgrad Med; 1980 Jan; 67(1):87-91, 94-8. PubMed ID: 6765989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New oral drugs for the treatment of congestive heart failure].
    Hayashida W; Kumada T; Kawai C
    Nihon Rinsho; 1992 Feb; 50(2):413-9. PubMed ID: 1319514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congestive heart failure. Towards a comprehensive treatment.
    Taylor SH
    Eur Heart J; 1996 Apr; 17 Suppl B():43-56. PubMed ID: 8733071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical treatment of cardiac insufficiency. Advances and controversies].
    Garnier LF
    Arch Mal Coeur Vaiss; 1988 Apr; 81(4):551-6. PubMed ID: 3136718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide: from bench to bedside.
    Adams KF; Mathur VS; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S34-46. PubMed ID: 12594450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.